Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
1.680
+0.020 (1.20%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Nexalin Technology Employees
Nexalin Technology had 6 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$28,120
Profits / Employee
-$1,267,864
Market Cap
22.35M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6 | 0 | - |
| Dec 31, 2023 | 6 | 0 | - |
| Dec 31, 2022 | 6 | -4 | -40.00% |
| Dec 31, 2021 | 10 | 6 | 150.00% |
| Dec 31, 2020 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
NXL News
- 3 days ago - Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders - GlobeNewsWire
- 15 days ago - Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial - GlobeNewsWire
- 22 days ago - Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3 - GlobeNewsWire
- 6 weeks ago - Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders - GlobeNewsWire
- 6 weeks ago - Nexalin Technology Announces Initiation of Patient Recruitment for UCSD's TBI & PTSD Clinical Study Following IRB Approval - GlobeNewsWire
- 7 weeks ago - Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board - GlobeNewsWire
- 2 months ago - Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment - GlobeNewsWire
- 2 months ago - Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition - GlobeNewsWire